Why Do People Get Cancer?
Adult cancers tend to be a little different from childhood cancers, and trying to explain the disease to a young person adds to the separation.… Read More »Why Do People Get Cancer?
Issues & Perspectives
Conversation With Dr. Claire Snyder About Ensuring Cancer Patients Get Best Care Possible
“During my nearly 20 years as a cancer researcher, I have always been impressed by how both my oncology and primary care colleagues don’t just… Read More »Conversation With Dr. Claire Snyder About Ensuring Cancer Patients Get Best Care Possible
Radiation Oncology Pioneer Moody Wharam, M.D., Dies at 77
Moody Wharam Jr., Professor Emeritus of Radiation Oncology and Molecular Radiation Sciences and former Willard and Lillian Hackerman Professor of Radiation Oncology at the Johns… Read More »Radiation Oncology Pioneer Moody Wharam, M.D., Dies at 77
A Look Inside the Kimmel Cancer Center’s Cancer Medicine Cabinet
Read the latest issue of Promise & Progress featuring research advances in cancer drug discovery and development, promising new cancer drugs, patient stories and more.… Read More »A Look Inside the Kimmel Cancer Center’s Cancer Medicine Cabinet
Differences and Disparities in Cancer
The good news is that there is an ongoing 1.5 percent annual decline in cancer death rates. The more troubling news is that cancer does… Read More »Differences and Disparities in Cancer
Pancreatic Cancer Awareness Month
It’s Pancreatic Cancer Awareness Month, so we wanted to gather our best Kimmel Cancer Center resources for you. Learn more about cancer vaccines and other… Read More »Pancreatic Cancer Awareness Month
Do you qualify for Social Security disability as a cancer patient? 5 tests
Social Security pays benefits for a medical condition that is expected to last for at least a year, or may result in death. Supplemental Security… Read More »Do you qualify for Social Security disability as a cancer patient? 5 tests
Historic cancer drug approval has roots at Johns Hopkins and its Bloomberg~Kimmel Institute laboratories and clinics
Breaking news today as, for the first time, a drug has been FDA-approved for cancer based on disease genetics rather than type. Developed from 30… Read More »Historic cancer drug approval has roots at Johns Hopkins and its Bloomberg~Kimmel Institute laboratories and clinics
Lung cancer immunotherapy options expand
Patients and doctors received news this week of the FDA’s approval of the immunotherapy drug pembrolizumab in combination with platinum doublet chemotherapy as first-line therapy for… Read More »Lung cancer immunotherapy options expand
Kimmel Cancer Center Joins Nation’s Cancer Centers in Supporting HPV Vaccination
The Johns Hopkins Kimmel Cancer Center joined all of the nation's cancer centers designated by the National Cancer Institute in endorsing human papillomavirus (HPV) vaccination… Read More »Kimmel Cancer Center Joins Nation’s Cancer Centers in Supporting HPV Vaccination